Status:

COMPLETED

Ginger and Gut Microbiome (GINGER)

Lead Sponsor:

University of Minnesota

Conditions:

Colorectal Adenoma

Eligibility:

All Genders

50-75 years

Phase:

NA

Brief Summary

Estimate the impact of a 6-week daily intake of 2000 mg of ginger extract on the composition of the gut microbiome using a randomized placebo-controlled double-blinded design, i.e. examine the change ...

Detailed Description

This is a pilot trial to evaluate the feasibility of conducting a large randomized trial and estimate the effects of ginger extract on the gut microbiome. The pilot study will recruit from multiple si...

Eligibility Criteria

Inclusion

  • Colorectal adenoma diagnosis

Exclusion

  • Allergy or sensitivity to ginger
  • Active cancer
  • Unstable medical condition
  • Unstable diet or weight

Key Trial Info

Start Date :

November 14 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 26 2020

Estimated Enrollment :

68 Patients enrolled

Trial Details

Trial ID

NCT03268655

Start Date

November 14 2018

End Date

June 26 2020

Last Update

July 22 2020

Active Locations (13)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (13 locations)

1

Mayo Clinic Cancer Center

Albert Lea, Minnesota, United States, 56007

2

Mayo Clinic Cancer Center

Austin, Minnesota, United States, 55912

3

Essentia Health - Deer River

Deer River, Minnesota, United States, 56636

4

Essentia Health St Mary's - Detroit Lakes

Detroit Lakes, Minnesota, United States, 56501